Elevated Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Hold |
12,407
| – | – | 0.73% | 33 |
|
|
2025
Q1 | $2.6M | Sell |
12,407
-682
| -5% | -$143K | 0.73% | 33 |
|
|
2024
Q4 | $2.33M | Buy |
13,089
+1,377
| +12% | +$245K | 0.63% | 35 |
|
|
2024
Q3 | $2.31M | Buy |
11,712
+1,995
| +21% | +$394K | 0.61% | 36 |
|
|
2024
Q2 | $1.67M | Sell |
9,717
-8,988
| -48% | -$1.54M | 0.47% | 58 |
|
|
2024
Q1 | $3.41M | Buy |
18,705
+324
| +2% | +$59K | 0.98% | 27 |
|
|
2023
Q4 | $2.85M | Buy |
18,381
+266
| +1% | +$41.2K | 0.89% | 30 |
|
|
2023
Q3 | $2.7M | Buy |
18,115
+1,131
| +7% | +$169K | 0.92% | 33 |
|
|
2023
Q2 | $2.29M | Buy |
16,984
+755
| +5% | +$102K | 0.76% | 39 |
|
|
2023
Q1 | $2.59M | Buy |
16,229
+36
| +0.2% | +$5.74K | 0.93% | 30 |
|
|
2022
Q4 | $2.62M | Buy |
16,193
+3,019
| +23% | +$488K | 1% | 30 |
|
|
2022
Q3 | $1.77M | Buy |
+13,174
| New | +$1.77M | 0.7% | 39 |
|
|
2022
Q1 | $2.13M | Buy |
+13,109
| New | +$2.13M | 0.7% | 38 |
|
|
2021
Q3 | $1.36M | Buy |
+12,588
| New | +$1.36M | 0.47% | 63 |
|
|
2021
Q1 | $1.27M | Buy |
11,670
+3,738
| +47% | +$407K | 0.49% | 67 |
|
|
2020
Q4 | $850K | Sell |
7,932
-734
| -8% | -$78.7K | 0.37% | 91 |
|
|
2020
Q3 | $857K | Sell |
8,666
-30
| -0.3% | -$2.97K | 0.4% | 90 |
|
|
2020
Q2 | $817K | Buy |
+8,696
| New | +$817K | 0.38% | 99 |
|
|
2019
Q4 | $441K | Buy |
+4,981
| New | +$441K | 0.49% | 61 |
|
|
2019
Q1 | $827K | Buy |
+10,103
| New | +$827K | 0.55% | 59 |
|